Login/Sign Up
₹162.9*
MRP ₹181
10% off
₹153.85*
MRP ₹181
15% CB
₹27.15 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Mignar25-MF Tablet SR
Mignar25-MF Tablet SR belongs to the class of medications called ‘antidiabetic drugs’ used to treat type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (utilizes glucose to produce energy) or if produced, it cannot function properly in the body.
Mignar25-MF Tablet SR contains Miglitol and Metformin. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Miglitol works by inhibiting intestinal enzymes that break complex sugars into simple sugars like glucose. Together, Mignar25-MF Tablet SR can effectively prevent the rise in glucose levels in the body.
You should take this medicine exactly as prescribed by the doctor. The common side-effects of Mignar25-MF Tablet SR are flatulence (gas), diarrhoea, abdominal pain, feeling sick (nausea), being sick (vomiting) and loss of appetite. These side effects can be reduced if this medicine is taken with food or after a meal. However, if any of these side effects persist or get worse, inform your doctor immediately.
It is not recommended to take Mignar25-MF Tablet SR if you are allergic to any contents of it. Mignar25-MF Tablet SR is not recommended if you are having any intestinal problems such as inflammation, ulcers, blockage, hernia, liver problems, severe kidney impairment, uncontrolled diabetes, severe dehydration, severe infections, and a recent history of heart attack or heart failure. Mignar25-MF Tablet SR is not recommended for children and adolescents below 18 years, pregnant women, and breastfeeding mothers. It should be used with caution in elderly people as they may require dose adjustments. Mignar25-MF Tablet SR may interact with alcohol and worsen the condition. Mignar25-MF Tablet SR may cause hypoglycemia (low glucose levels), so avoid driving if you develop weakness, dizziness, fast heartbeat, or decrease in alertness.
Uses of Mignar25-MF Tablet SR
Medicinal Benefits
Mignar25-MF Tablet SR is a combination of two drugs: Miglitol and Metformin. This combination therapy is preferred in patients with poorly controlled diabetes. It reduces blood glucose levels, especially post-prandial glucose levels (glucose levels after meals) in type 2 diabetes mellitus patients. An increase in post-prandial glucose levels can be a risk factor for diabetes complications such as tissue and organ damage. So, a decrease in glucose levels helps control diabetes, reduce this risk and improve healthy life.
Side Effects of Mignar25-MF Tablet SR
Directions for Use
Storage
Drug Warnings
Mignar25-MF Tablet SR may cause a rare and serious side effect ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body. Consumption of alcohol, prolonged fasting, dehydration, uncontrolled diabetes, serious infections, and liver problems increases the risk of lactic acidosis. If you have dehydration (severe loss of body fluids) due to severe vomiting, diarrhoea, exposure to heat, or fever, stop taking Mignar25-MF Tablet SR and immediately seek medical attention. Mignar25-MF Tablet SR may cause hypoglycemia (low blood sugar) and its symptoms include sweating, dizziness, palpitations (pounding heartbeat), and shivering, etc. Whenever you experience any of these symptoms, immediately consume candies or glucose biscuits rather than ordinary sugar. If your condition doesn’t improve, consult your doctor immediately.
Therapeutic Class
Diet & Lifestyle Advise
Habit Forming
How Mignar25-MF Tablet SR Works
What if I have taken an overdose of Mignar25-MF Tablet SR
Alcohol
Unsafe
Consumption of alcohol may increase the risk of side effects and worsen the condition.
Pregnancy
Caution
Mignar25-MF Tablet SR is a category B medicine and may not cause harmful effects to the unborn baby. However, it should be used in pregnant women only if clinically needed.
Breast Feeding
Unsafe
Mignar25-MF Tablet SR should not be given to breastfeeding mothers as it may pass in breast milk and cause adverse effects in the nursing baby.
Driving
Caution
Mignar25-MF Tablet SR may impair alertness or decrease concentration, so avoid driving or operating heavy machinery in such cases.
Liver
Caution
Mignar25-MF Tablet SR should be used with caution in patients with liver diseases. The dose may have to be adjusted by your doctor.
Kidney
Caution
Mignar25-MF Tablet SR is not recommended for use in patients with severe kidney impairment. In patients with mild to moderate kidney diseases, your doctor may have to adjust the dose.
Children
Unsafe
Mignar25-MF Tablet SR is not recommended for children and adolescents below 18 years of age.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes